138 related articles for article (PubMed ID: 16213358)
21. Frequency of loss of heterozygosity at 3 p, 9 p, 13 q, and 17 p is related to proliferative activity in smokers with stage I non-small cell lung cancer.
Haga Y; Hiroshima K; Iyoda A; Kohno H; Shibuya K; Iizasa T; Fujisawa T; Ohwada H
Thorac Cardiovasc Surg; 2005 Apr; 53(2):114-7. PubMed ID: 15786011
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.
Sanchez-Cespedes M; Ahrendt SA; Piantadosi S; Rosell R; Monzo M; Wu L; Westra WH; Yang SC; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(4):1309-13. PubMed ID: 11245426
[TBL] [Abstract][Full Text] [Related]
23. Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer.
Field JK; Liloglou T; Xinarianos G; Prime W; Fielding P; Walshaw MJ; Turnbull L
Cancer Res; 1999 Jun; 59(11):2690-5. PubMed ID: 10363993
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas.
Herzog CR; Chen B; Wang Y; Schut HA; You M
Mol Carcinog; 1996 Jun; 16(2):83-90. PubMed ID: 8645430
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
26. Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.
Wongsurawat VJ; Finley JC; Galipeau PC; Sanchez CA; Maley CC; Li X; Blount PL; Odze RD; Rabinovitch PS; Reid BJ
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):509-16. PubMed ID: 16537709
[TBL] [Abstract][Full Text] [Related]
27. Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis.
Geurts TW; van Velthuysen ML; Broekman F; van Huysduynen TH; van den Brekel MW; van Zandwijk N; van Tinteren H; Nederlof P; Balm AJ; Brakenhoff RH
Clin Cancer Res; 2009 Feb; 15(3):980-5. PubMed ID: 19188169
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
29. Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma.
Ahmadian A; Ren ZP; Williams C; Pontén F; Odeberg J; Pontén J; Uhlén M; Lundeberg J
Oncogene; 1998 Oct; 17(14):1837-43. PubMed ID: 9778050
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer.
Powell CA; Klares S; O'Connor G; Brody JS
Clin Cancer Res; 1999 Aug; 5(8):2025-34. PubMed ID: 10473082
[TBL] [Abstract][Full Text] [Related]
31. LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer.
Sanz-Ortega J; Bryant B; Sanz-Esponera J; Asenjo JA; Saez MC; Torres A; Balibrea JL; Sobel ME; Merino MJ
Pathol Res Pract; 1999; 195(10):677-80. PubMed ID: 10549031
[TBL] [Abstract][Full Text] [Related]
32. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.
Kang JU; Koo SH; Kwon KC; Park JW
Int J Oncol; 2010 Aug; 37(2):327-35. PubMed ID: 20596660
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.
Hirao S; Hirao T; Marsit CJ; Hirao Y; Schned A; Devi-Ashok T; Nelson HH; Andrew A; Karagas MR; Kelsey KT
Cancer; 2005 Nov; 104(9):1918-23. PubMed ID: 16149093
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers.
Abujiang P; Mori TJ; Takahashi T; Tanaka F; Kasyu I; Hitomi S; Hiai H
Oncogene; 1998 Dec; 17(23):3029-33. PubMed ID: 9881705
[TBL] [Abstract][Full Text] [Related]
36. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J
Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype.
Chapman EJ; Harnden P; Chambers P; Johnston C; Knowles MA
Clin Cancer Res; 2005 Aug; 11(16):5740-7. PubMed ID: 16115911
[TBL] [Abstract][Full Text] [Related]
39. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
[TBL] [Abstract][Full Text] [Related]
40. Genetic progression and divergence in superficial esophageal squamous cell carcinoma by loss of heterozygosity analysis.
Shima H; Hiyama T; Tanaka S; Yoshihara M; Arihiro K; Chayama K
Oncol Rep; 2006 Oct; 16(4):685-91. PubMed ID: 16969480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]